doi: 10.1126/science.6546809.
Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide
- PMID: 6546809
- DOI: 10.1126/science.6546809
Item in Clipboard
Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide
Science.
.
Abstract
Exogenous cholecystokinin selectively antagonizes opiate analgesia, which suggests that endogenous cholecystokinin may act physiologically as an opiate antagonist and may play a role in opiate tolerance. The use of the selective cholecystokinin antagonist proglumide provided a test of these hypotheses in rats that were either inexperienced with or tolerant to opiates. Proglumide potentiated analgesia produced by morphine and endogenous opiates and seemed to reverse tolerance. These results suggest that endogenous cholecystokinin systems oppose the action of opiates.
Similar articles
-
Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist.Anesth Analg. 1985 Aug;64(8):801-6. Anesth Analg. 1985. PMID: 4014744
-
Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates.Brain Res. 1985 Feb 18;327(1-2):181-90. doi: 10.1016/0006-8993(85)91512-4. Brain Res. 1985. PMID: 3838691
-
Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.Brain Res. 1985 Feb 18;327(1-2):169-80. doi: 10.1016/0006-8993(85)91511-2. Brain Res. 1985. PMID: 3838690
-
Multiple endogenous opiate and non-opiate analgesia systems: evidence of their existence and clinical implications.Ann N Y Acad Sci. 1986;467:273-99. doi: 10.1111/j.1749-6632.1986.tb14635.x. Ann N Y Acad Sci. 1986. PMID: 3014973 Review. No abstract available.
-
Neurophysiological effects of opiates in the CNS.Monogr Neural Sci. 1987;13:132-60. doi: 10.1159/000414574. Monogr Neural Sci. 1987. PMID: 3317012 Review. No abstract available.
Cited by
-
CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat.Br J Pharmacol. 1992 Mar;105(3):591-6. doi: 10.1111/j.1476-5381.1992.tb09024.x. Br J Pharmacol. 1992. PMID: 1628146 Free PMC article.
-
Design and synthesis of trivalent ligands targeting opioid, cholecystokinin, and melanocortin receptors for the treatment of pain.Bioorg Med Chem Lett. 2010 Jul 15;20(14):4080-4. doi: 10.1016/j.bmcl.2010.05.078. Epub 2010 May 24. Bioorg Med Chem Lett. 2010. PMID: 20547453 Free PMC article.
-
PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes.Proc Natl Acad Sci U S A. 1990 Sep;87(18):7105-9. doi: 10.1073/pnas.87.18.7105. Proc Natl Acad Sci U S A. 1990. PMID: 1698290 Free PMC article.
-
A locus and mechanism of action for associative morphine tolerance.Nat Neurosci. 2000 Jan;3(1):47-53. doi: 10.1038/71120. Nat Neurosci. 2000. PMID: 10607394 Free PMC article.
-
Cholecystokinin and pain: a review.Anesth Prog. 1986 Mar-Apr;33(2):87-90. Anesth Prog. 1986. PMID: 2872841 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
